$6.5 0.1 1.9%
Last Trade - 24/02/21
| Market Cap | ÂŁ39.6m |
| Enterprise Value | ÂŁ48.0m |
| Revenue | ÂŁn/a |
| Position in Universe | 5446th / 6714 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
| Last Annual | December 31st, 2019 |
| Last Interim | December 31st, 2019 |
| Incorporated | December 2, 2007 |
| No. of Shareholders: | n/a |
| No. of Employees: | 3 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Capital Market |
| Shares in Issue | 8,758,016 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 4 Bruria St, TEL AVIV-YAFO, 6745442, Israel |
| Web | http://www.painreform.com |
| Phone | +972 9 9601901 |
| Contact | () |
| Auditors | Brightman Almagor Zohar & Co |
As of 24/02/21, shares in PainReform are trading at $6.5, giving the company a market capitalisation of ÂŁ39.6m. This share price information is delayed by 15 minutes.
Shares in PainReform are currently trading at $6.5 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PainReform price has moved by % over the past year.
There are no analysts currently covering PainReform.
PainReform is scheduled to issue upcoming financial results on the following dates:
PainReform does not currently pay a dividend.
PainReform does not currently pay a dividend.
PainReform does not currently pay a dividend.
To buy shares in PainReform you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in PainReform are currently trading at $6.5, giving the company a market capitalisation of ÂŁ39.6m.
Here are the trading details for PainReform:
Based on an overall assessment of its quality, value and momentum, PainReform is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for PainReform.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PainReform. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $6.5, shares in PainReform are trading at 31.2% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for PainReform.
We were unable to find the directors for PainReform.
Here are the top five shareholders of PainReform based on the size of their shareholding:
